Convertible securities sold between A$165,000 and A$1 million apiece
By Devika Patel
Knoxville, Tenn., July 3 - Novogen Ltd. plans a $5 million three-year funding agreement that will sell 0% convertible securities, according to a 6-K filed Wednesday with the Securities and Exchange Commission.
Novogen will sell up to 5 securities at prices ranging from A$165,000 to A$1 million. The first investment of $1 million will be made immediately by selling a converted security with a face value of A$1.1 million. There must be a minimum of 120 days between tranches.
The notes are convertible into shares at either 90% of the average of three daily volume-weighted average prices during the 20 consecutive trading days immediately prior to the conversion notice date or 130% of the average of the daily volume-weighted average prices for the 20 consecutive trading days immediately prior to the agreement's execution.
The investor will also receive options, which are exercisable at 130% of the average daily volume-weighted average prices for the 20 consecutive trading days immediately prior to July 2.
Proceeds will be used to bring CS-6 through into the clinic and identify a panel of phenotype-specific anti-cancer drugs for personalized chemotherapy.
Novogen is a biotechnology company based in Sydney, Australia.
Issuer: | Novogen Ltd.
|
Issue: | Convertible securities
|
Amount: | $5 million
|
Notes: | 5
|
Price: | A$165,000 to A$1 million
|
Coupon: | 0%
|
Conversion price: | Either 90% of the average of three daily volume-weighted average prices during the 20 consecutive trading days immediately prior to the conversion notice date or 130% of the average of the daily volume-weighted average prices for the 20 consecutive trading days immediately prior to the agreement's execution
|
Options: | Yes
|
Option strike price: | 130% of the average daily volume-weighted average prices for the 20 consecutive trading days immediately prior to July 2
|
Pricing date: | July 3
|
Stock symbol: | Australia: NRT
|
Stock price: | A$0.19 at close July 2
|
Market capitalization: | A$20.1 million
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.